Our Story

Supporting exceptional science and technology

Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.

Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential.

Malin is headquartered in Ireland and listed on the Euronext Growth Market of Euronext Dublin.


To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies

Investee Companies

Access to companies with compelling
value propositions spanning innovations
across multiple areas of healthcare
Delivery of transformative
outcomes for patients


Our Core Values

Science and innovation

We have deployed capital to support and actively work with companies developing ground-breaking innovative technology platforms in pursuit of cures for cancer and autoimmune and other diseases where current therapies are suboptimal or do not exist.


We work closely with talented individuals across our investee companies who share our goal of creating transformative new therapies for patients, particularly those with life threatening illnesses.

Business Integrity

We operate the business with integrity and veracity with the best interests of our key stakeholders in mind. We seek to make a capital return for our investors while helping in the development of new therapies for patients.

Investment Focus

Investing in innovative life sciences & healthcare technologies with potential to reach near-term significant value inflection or realisation points

Delivery of transformative outcomes for patients

Therapeutic areas of focus: oncology, immunology & genetic diseases